Dr. Corinne Hohl, an Associate Professor at the UBC Department of Emergency Medicine, received a major 1.16M CIHR operating grant to support her research on reducing adverse drug events (ADEs), the unintended and harmful events associated with medications.
Her project “When Treatments Harm: Building Better Systems and Enhancing Research Capacity to Reduce Adverse Drug Events” will include multiple research objectives and also aims to train the next generation of health researchers to tackle this pervasive problem. Knowledge translation is an essential component of the program. Dr. Hohl has formed strong partnerships with not-for-profit organisations, policy makers and industry which will allow the findings to be disseminated and ensure rapid uptake of her findings.
The potential impacts of this research program include improving clinical care delivery by preventing and mitigating adverse drug events, improving health outcomes, and enabling more efficient and less costly healthcare.